The expression of sialic acid-binding immunoglobulin-like lectin 1 on peripheral mononuclear cells in patients with coronary heart disease and its clinical significance
10.3760/cma.j.issn.1009-9158.2009.07.011
- VernacularTitle:唾液酸结合免疫球蛋白样凝集素1在冠状动脉粥样硬化性心脏病患者外周血单个核细胞的表达及临床意义
- Author:
Yisong XIONG
;
Yunheng ZHOU
;
Weilin WU
;
Lingzhen ZHANG
;
Yan LIANG
;
Zaixing YANG
;
Honglian GENG
;
Hao WANG
;
Aihua WANG
;
Guanghua RONG
;
Renqian ZHONG
- Publication Type:Journal Article
- Keywords:
Coronary disease;
Leukocytes,mononuclear;
Membrane glycoproteins;
Receptors,immunologic;
Flow cytometry
- From:
Chinese Journal of Laboratory Medicine
2009;32(7):772-776
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of sialic acid-binding immunoglobulin-like lectin-one (Siglec-1, also called CD169) in lymphocytes, monocytes and neutrophils in peripheral blood in patients with coronary heart disease(CHD), and explore the relationship between Siglec-1 expression and atheresclerosis. Methods CD145 CD169 positive cell proportion and CD169 mRNA levels were respectively measured by flow cytometry and real-time quantitative reverse transcription-polymerase chain reaction (FQ-RT-PCR) in 57 CHD patients and 38 healthy controls. And the levels of serum hpids were determined by automatic biochemistry analyzer. Results The flow cytometry analysis showed that CD169 protein was not found in lymphocytes and neutrophils in both CHD patients and healthy controls. The rate of CD14 CD169 double positive ceils in monocytes in CHD group was significandy higher than that in healthy controls [(12.7±2.4)% vs (1.0±0.3)% ,t =23.2,P<0.01]. And FQ-RT-PCR analysis showed that the mean CD± mRNA copy number in PBMCs in CHD group was significantly higher(3.2 fold) than that in healthy controls [t = 6. 59, P < 0.01]. However, neither differences of CD169 protein positivities [[(12. 2 ± 2. 3) %vs (13.4±2.5)% ,t = 1.87,P >0.05] nor mRNA levels [3.64 fold vs 2.79 fold when compared with healthy controls,t =0. 98, P > 0. 05] were found between CHD patients with normal and abnormal levels of serum Lipids. Conclusions CD169 is mainly expressed in human tissue-resident macrophages but not expressed in peripheral blood monecytes. And when the monocytes is stimulated by inflammation, the expression of CD169 is increased. In patients with CHD, the increased expression of CD169 protein and mRNA level has demonstrated the activation of monocytes in peripheral blood. CD169 and CD169-mediated monocytes activation may play an important role in the development and progression of atherosclerosis.
